Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Neuropharmacology. 2009 Jul 9;58(1):88–101. doi: 10.1016/j.neuropharm.2009.06.040

Table 7.

This table summarize results from the mPFC chronic treatment (session 10) analyzed by gcRMA.

Gene Title Fold
Change
Rattus norvegicus Transthyretin (prealbumin, amyloidosis type I) (Ttr), mRNA. 7.6
ESTs 4.9
ESTs, Highly similar to gene rich cluster, C9 gene [Mus musculus] [M.musculus] 4.2
ESTs, Highly similar to RPB5_HUMAN DNA-directed RNA polymerase II 23 kDa
polypeptide		 2.1
Rattus norvegicus macrophage-derived chemokine mRNA, partial cds. −3.4
Rattus norvegicus zinc finger protein HIT-4 mRNA, complete cds. 3.1
ESTs, Moderately similar to protein tyrosine phosphatase 4a1 [Rattus norvegicus] 3.1
Rattus norvegicus smooth muscle cell LIM protein (SmLIM) mRNA, complete cds. 4
ESTs −3.3
Rattus norvegicus mRNA for phosphatidylinositol 3-kinase p45 subunit, complete cds. 2.6
ESTs, Highly similar to BAG2_HUMAN BAG-family molecular chaperone regulator-2 −3.4
ESTs, Moderately similar to RIKEN cDNA 0610009O03 [Mus musculus] 2.6
ESTs, Moderately similar to tyrosyl-DNA phosphodiesterase [Homo sapiens] 2.2
Rattus norvegicus leukotriene C4 synthase (Ltc4s), mRNA. 2.1